i iii 1. iA ipatient’s inutritional iintake iand ilaboratory iresults ireflect ihypoalbuminemia. iThis iis icritical ito
iprescribing ibecause:
1. Distribution iof idrugs ito itarget itissue imay ibe iaffected.
2. The isolubility iof ithe idrug iwill inot imatch ithe isite iof iabsorption.
3. There iwill ibe iless ifree idrug iavailable ito igenerate ian ieffect.
4. Drugs ibound ito ialbumin iare ireadily iexcreted iby ithe ikidneys.
i iii 2. iDrugs ithat ihave ia isignificant ifirst-pass i effect:
1. Must ibe igiven iby ithe ienteral i(oral) iroute ionly
2. Bypass ithe ihepatic icirculation
3. Are irapidly imetabolized iby ithe iliver iand imay ihave ilittle iif iany idesired iaction
4. Are iconverted iby ithe iliver ito imore iactive iand ifat-soluble iforms
i iii 3. iThe iroute iof iexcretion iof ia ivolatile idrug iwill ilikely ibe ithe:
1. Kidneys
2. Lungs
3. Bile iand ifeces
4. Skin
i iii 4. iMedroxyprogesterone i(Depo iProvera) iis iprescribed iintramuscularly i(IM) ito icreate ia istorage
ireservoir iof ithe idrug. iStorage ireservoirs:
1. Assure ithat ithe idrug iwill ireach iits iintended itarget itissue
2. Are ithe ireason ifor igiving iloading idoses
3. Increase ithe ilength iof itime ia idrug iis iavailable iand iactive
4. Are imost icommon iin icollagen itissues
i iii 5. iThe iNP ichooses ito igive icephalexin ievery i8 ihours ibased ion iknowledge iof ithe idrug’s:
1. Propensity ito igo ito ithe itarget ireceptor
2. Biological ihalf-life
3. Pharmacodynamics
4. Safety iand iside ieffects
, i iii 6. iAzithromycin idosing irequires ithat ithe ifirst iday’s idosage ibe itwice ithose iof ithe iother i4 idays iof ithe
iprescription. iThis iis iconsidered ia iloading idose. iA iloading idose:
1. Rapidly iachieves idrug ilevels iin ithe itherapeutic irange
2. Requires ifour- ito ifive-half-lives ito iattain
3. Is iinfluenced iby irenal ifunction
4. Is idirectly irelated ito ithe idrug icirculating ito ithe itarget itissues
i iii 7. iThe ipoint iin itime ion ithe idrug iconcentration icurve ithat iindicates ithe ifirst isign iof ia itherapeutic ieffectiis
ithe:
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller KATLEGOO. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R133,00. You're not tied to anything after your purchase.